|
US4977189A
(en)
*
|
1986-05-07 |
1990-12-11 |
American Cyanamid Company |
Substituted guanidinedicarbonyl derivatives
|
|
JPH07188197A
(ja)
|
1993-11-17 |
1995-07-25 |
Fujisawa Pharmaceut Co Ltd |
オキサゾール誘導体
|
|
DE4344550A1
(de)
|
1993-12-24 |
1995-06-29 |
Hoechst Ag |
Substituierte 1-Oxo-1,2-dihydro-isochinolinoyl- und 1,1-Dioxo-2H-1,2-benzothiazinoylguanidine, Verfahrenzu ihrer Herstellung, ihre Verwendung als Medikamentt oder Diagnostikum sowie sie enthaltendes Medikamen
|
|
US7041702B1
(en)
|
1997-10-21 |
2006-05-09 |
Scion Pharmaceuticals, Inc. |
Pharmaceutically active compounds and methods of use
|
|
EP1156803A4
(en)
|
1999-02-09 |
2004-03-17 |
Bristol Myers Squibb Co |
FXA LACTAM INHIBITORS AND METHOD
|
|
US7276348B2
(en)
|
1999-04-30 |
2007-10-02 |
Regents Of The University Of Michigan |
Compositions and methods relating to F1F0-ATPase inhibitors and targets thereof
|
|
CN1202095C
(zh)
|
1999-07-15 |
2005-05-18 |
住友制药株式会社 |
杂芳环化合物
|
|
BR0111878A
(pt)
|
2000-06-30 |
2005-05-24 |
Bristol Myers Squibb Co |
N-ureido-(heterociclo-alquil)-piperidinas como moduladores da atividade de receptores de quimiocinas
|
|
AU2002357137A1
(en)
|
2001-12-10 |
2003-06-23 |
Bristol-Myers Squibb Company |
(1-phenyl-2-heteroaryl)ethyl-guanidine compounds as inhibitors of mitochondrial f1f0 atp hydrolase
|
|
GB0208224D0
(en)
|
2002-04-10 |
2002-05-22 |
Celltech R&D Ltd |
Chemical compounds
|
|
US20040009972A1
(en)
|
2002-06-17 |
2004-01-15 |
Ding Charles Z. |
Benzodiazepine inhibitors of mitochondial F1F0 ATP hydrolase and methods of inhibiting F1F0 ATP hydrolase
|
|
US7109224B2
(en)
|
2002-11-06 |
2006-09-19 |
Bristol-Myers Squibb Co. |
Acyl guanidine compounds and use thereof
|
|
CA2508914A1
(en)
|
2002-12-04 |
2004-06-17 |
Gene Logic Inc. |
Modulators of melanocortin receptor
|
|
DE102004008141A1
(de)
|
2004-02-19 |
2005-09-01 |
Abbott Gmbh & Co. Kg |
Guanidinverbindungen und ihre Verwendung als Bindungspartner für 5-HT5-Rezeptoren
|
|
US20050272723A1
(en)
|
2004-04-27 |
2005-12-08 |
The Regents Of The University Of Michigan |
Methods and compositions for treating diseases and conditions associated with mitochondrial function
|
|
US20090275099A1
(en)
|
2004-04-27 |
2009-11-05 |
Regents Of The University Of Michigan |
Methods and compositions for treating diseases and conditions associated with mitochondrial function
|
|
JP4990766B2
(ja)
|
2004-07-01 |
2012-08-01 |
シンタ ファーマシューティカルズ コーポレーション |
二置換型ヘテロアリール化合物
|
|
EP2037741B1
(en)
|
2006-06-09 |
2013-11-27 |
The Regents Of The University Of Michigan |
Benzodiazepine derivatives for use in the treatment of immune, inflammatory and proliferative disorders
|
|
JP5416122B2
(ja)
|
2007-09-14 |
2014-02-12 |
ザ リージェンツ オブ ザ ユニバーシティ オブ ミシガン |
Ｆ１Ｆ０−ＡＴＰａｓｅインヒビターおよび関連の方法
|
|
US8642660B2
(en)
|
2007-12-21 |
2014-02-04 |
The University Of Rochester |
Method for altering the lifespan of eukaryotic organisms
|
|
KR100982661B1
(ko)
|
2008-04-22 |
2010-09-17 |
전남대학교산학협력단 |
플라스멥신 ⅱ 활성을 저해하는 화합물을 유효성분으로함유하는 말라리아 예방 및 치료를 위한 약학 조성물 및이를 이용한 말라리아 치료방법
|
|
JP5567573B2
(ja)
|
2008-09-11 |
2014-08-06 |
ザ リージェンツ オブ ザ ユニバーシティ オブ ミシガン |
アリールグアニジンｆ１ｆ０−ａｔｐアーゼ阻害剤およびそれと関連する方法
|
|
DK2648511T3
(en)
|
2010-12-08 |
2017-09-18 |
Lycera Corp |
PYRAZOLYLGUANIDINE-F1F0 ATPASE INHIBITORS AND THERAPEUTIC APPLICATIONS THEREOF
|
|
CN103458886B
(zh)
|
2010-12-08 |
2016-06-08 |
莱斯拉公司 |
吡啶酮基胍f1f0-atp酶抑制剂及其治疗用途
|
|
US9169199B2
(en)
|
2010-12-08 |
2015-10-27 |
Lycera Corporation |
Cycloalkyl guanidine F1F0-ATPase inhibitors and therapeutic uses thereof
|
|
AU2011338302A1
(en)
|
2010-12-08 |
2013-07-11 |
Lycera Corporation |
Cycloalkyl guanidine F1F0-ATPase inhibitors and therapeutic uses thereof
|
|
US9221814B2
(en)
|
2012-06-08 |
2015-12-29 |
Lycera Corporation |
Heterocyclic guanidine F1F0-atpase inhibitors and therapeutic uses thereof
|
|
EP2866796A4
(en)
|
2012-06-08 |
2015-11-25 |
Lycera Corp |
PYRAZOLYL GUANIDINE F1FO ATPASE HEMMER AND THERAPEUTIC USES THEREOF
|
|
US9580391B2
(en)
|
2012-06-08 |
2017-02-28 |
Lycera Corporation |
Saturated acyl guanidine for inhibition of F1F0-ATPase
|
|
WO2015089152A1
(en)
|
2013-12-10 |
2015-06-18 |
Lycera Corporation |
N-substituted pyrazolyl guanidine f1f0-atpase inhibitors and therapeutic uses thereof
|
|
BR112016013116A8
(pt)
|
2013-12-10 |
2020-05-12 |
Lycera Corp |
inibidores de trifluorometil pirazolil guanidina f1f0-atpase, seus usos, e composições farmacêuticas
|
|
WO2015089131A1
(en)
*
|
2013-12-10 |
2015-06-18 |
Lycera Corporation |
Alkylpyrazolyl guanidine f1f0-atpase inhibitors and therapeutic uses thereof
|